Document is current
Any future updates will be listed below
-
Authors
Sato, Yuka
Feig, Daniel I.
Stack, Austin G.
Kang, Duk-Hee
Lanaspa, Miguel A.
Ejaz, A. Ahsan
Sánchez-Lozada, L. Gabriela
Kuwabara, Masanari https://orcid.org/0000-0002-6601-4347
Borghi, Claudio
Johnson, Richard J. https://orcid.org/0000-0003-3312-8193
- License Information
-
More Information
Article History
First Online: 20 April 2020
Competing interests
: A.G.S. has had an unrestricted educational grant from Menarini International Operations Luxemburg and has consulted for Menarini and Grunenthal Pharma. G.S.-L. has had funding from Relburn Metabolomic and Danone Research Foundation; R.J.J. has equity with XORT Therapeutics, which is developing novel xanthine oxidase inhibitors, is an inventor on several patents on the role of uric acid in hypertension, metabolic syndrome and diabetic nephropathy that resulted from research (US Patent No. 7,799,794; US Patent No. 8,236,488; US Patent No. 8,557,831; US Patent No. 9,155,740 B), and has consulted for Danone Research Foundation, Horizon Pharmaceuticals and Astra Zeneca.
